Home > Insider Trading > Filing (0001567619-19-012279)

Filing Details

Accession Number:: 0001567619-19-012279
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-05-28 20:40:19
Reporting Period:: 2019-05-28

Accepted Time:: 2019-05-28 20:40:19
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1676725	Ideaya Biosciences Inc.	IDYA	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1219014	M Scott Rocklage	C/O 5Am Ventures 501 Second Street, Suite 350 San Francisco CA 94107	No	No	Yes	No
1589314	5Am Partners Iv, Llc	2200 Sand Hill Road, Suite 110 Menlo Park CA 94025	No	No	Yes	No
1589315	5Am Ventures Iv, L.p.	C/O 5Am Ventures 501 Second Street, Suite 350 San Francisco CA 94107	No	No	Yes	No
1593361	5Am Co-Investors Iv, L.p.	501 Second Street, Suite 350 San Francisco CA 94107	No	No	Yes	No
1598549	J. Andrew Schwab	C/O 5Am Ventures 501 Second Street, Suite 350 San Francisco CA 94107	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-05-28	1,721,898	$0.00	2,026,098	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2019-05-28	578,447	$0.00	2,604,545	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2019-05-28	71,745	$0.00	84,420	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2019-05-28	24,101	$0.00	108,521	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2019-05-28	240,000	$10.00	2,844,545	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-05-28	10,000	$10.00	118,521	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-05-28	500,000	$10.00	500,000	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2019-05-28	1,721,898	$0.00	1,721,898	$0.00
Common Stock	Series B Preferred Stock	Disposition	2019-05-28	578,447	$0.00	578,447	$0.00
Common Stock	Series A Preferred Stock	Disposition	2019-05-28	71,745	$0.00	71,745	$0.00
Common Stock	Series B Preferred Stock	Disposition	2019-05-28	24,101	$0.00	24,101	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

Reflects a 1-for-10.2564 reverse stock split of the Issuer's outstanding securities effected prior to the effectiveness of the Issuer's S-1 Registration Statement.
Each share of Series A Preferred Stock was automatically converted on a 1-for-1 basis into Common Stock immediately prior to the closing of the Issuer's initial public offering.
The shares are held by 5AM Ventures IV, L.P. ("Ventures IV"). 5AM Partners IV, LLC ("Partners IV") is the sole general partner of Ventures IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage, are the managing members of Partners IV, and have shared voting and investment power over the shares beneficially owned by Ventures IV. Each of Partners IV, Dr. Diekman, Mr. Schwab, and Dr. Rocklage disclaims beneficial ownership of such shares except to the extent of its or their pecuniary interest therein.
Each share of Series B Preferred Stock was automatically converted on a 1-for-1 basis into Common Stock immediately prior to the closing of the Issuer's initial public offering.
The shares are held by 5AM Co-Investors IV, L.P. ("Co-Investors IV"). Partners IV is the sole general partner of Co-Investors IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage, are the managing members of Partners IV, and have shared voting and investment power over the shares beneficially owned by Co-Investors IV. Each of Partners IV, Dr. Diekman, Mr. Schwab, and Dr. Rocklage disclaims beneficial ownership of such shares except to the extent of its or their pecuniary interest therein.
The shares are held by 5AM Opportunities I, L.P. ("Opportunities I"). 5AM Opportunities I (GP), LLC ("Opportunities I GP") is the sole general partner of Opportunities I. Kush Parmar and Andrew J. Schwab are the managing members of Opportunities I GP, and have shared voting and investment power over the shares beneficially owned by Opportunities I. Each of Opportunities I GP and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his pecuniary interest therein.